Top compounds associated with response to BMF


Feature Type Standardized
Nominal ANOVA
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.17 6e-07
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.2 1e-06
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA PI-103 CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 6e-06
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.17 7e-06
mRNA PF-184 CTRPv2 pan-cancer AAC 0.15 8e-06
mRNA PL-DI CTRPv2 pan-cancer AAC 0.14 1e-05
Download CSV